Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Common Stock and Stockholders??? Equity (Deficit)

v3.23.3
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Common Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Contingently Redeemable Convertible Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 [1]   22,959,000 0      
Temporary equity, balances at beginning of period at Dec. 31, 2021 [1]   $ 487,918 $ 0      
Redeemable Convertible Preferred Stock            
Issuance of stock (in shares) [1]   34,000        
Issuance of stock [1]   $ 989        
Issuance of contingently convertible common stock (in shares) [1]     550,000      
Issuance of contingently convertible common stock [1]     $ 27,473      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [1]   (22,993,000) (550,000)      
Convertible preferred stock and contingently redeemable common stock conversion [1]   $ (488,907) $ (27,473)      
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2022 [1]   0 0      
Temporary equity, balances at ending of period at Sep. 30, 2022 [1]   $ 0 $ 0      
Balances at beginning of period (in shares) at Dec. 31, 2021 [1]       1,874,000    
Balances at beginning of period at Dec. 31, 2021 $ (456,279)     $ 0 [1] $ 33,864 $ (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of shares under ELOC Agreement (in shares)       8,000    
Issuance of shares under ELOC Agreement 138       138  
Issuance of shares to settle Additional Shares Liability (in shares)       655,000    
Issuance of shares to settle Additional Shares Liability 16,310       16,310  
Issuance of common stock upon exercise of stock options (in shares) [1]       43,000    
Issuance of common stock upon exercise of stock options 354       354  
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [1]       36,000    
Issuance of preferred stock and common stock upon net exercise of warrants 12       12  
Issuance of common stock warrants 2,182       2,182  
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [1]       23,640,000    
Convertible preferred stock and contingently redeemable common stock conversion 516,380     $ 2 [1] 516,378  
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs (in shares) [1]       4,184,000    
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,468     $ 1 79,467  
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)       (93,196)  
Issuance of Earn-Out Shares (in shares) [1]       2,800,000    
Issuance of Earn-Out Shares 1     $ 0 1  
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [1]       6,000    
Issuance of Class A common stock issued to employees, net of withholding taxes (96)       (96)  
Vesting of early exercise of options 125       125  
Repurchase of early exercised options (in shares) [1]       (3,000)    
Stock-based compensation 34,668       34,668  
Net loss (75,032)         (75,032)
Balances at ending of period (in shares) at Sep. 30, 2022 [1]       33,243,000    
Balances at ending of period at Sep. 30, 2022 25,035     $ 3 [1] 590,207 (565,175)
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2022 [1]   0 0      
Temporary equity, balances at ending of period at Sep. 30, 2022 [1]   $ 0 $ 0      
Balances at beginning of period (in shares) at Jun. 30, 2022       32,573,000    
Balances at beginning of period at Jun. 30, 2022 (8,478)     $ 3 564,356 (572,837)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of shares under ELOC Agreement (in shares)       8,000    
Issuance of shares under ELOC Agreement 138       138  
Issuance of shares to settle Additional Shares Liability (in shares)       655,000    
Issuance of shares to settle Additional Shares Liability 16,310       16,310  
Issuance of common stock upon exercise of stock options (in shares)       2,000    
Issuance of common stock upon exercise of stock options 21       21  
Issuance of common sock upon exercise of warrants (in shares)       5,000    
Issuance of common stock upon exercise of warrants 12       12  
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs (513)       (513)  
Stock-based compensation 9,883       9,883  
Net loss 7,662         7,662
Balances at ending of period (in shares) at Sep. 30, 2022 [1]       33,243,000    
Balances at ending of period at Sep. 30, 2022 $ 25,035     $ 3 [1] 590,207 (565,175)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2022 0          
Temporary equity, balances at beginning of period at Dec. 31, 2022 $ 0          
Redeemable Convertible Preferred Stock            
Issuance of stock (in shares) 10,000          
Issuance of stock $ 9,024          
Accretion on redeemable convertible preferred stock $ 976          
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2023 10,000          
Temporary equity, balances at ending of period at Sep. 30, 2023 $ 10,000          
Balances at beginning of period (in shares) at Dec. 31, 2022       35,571,000    
Balances at beginning of period at Dec. 31, 2022 26,533     $ 4 604,387 (577,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of shares to settle Additional Shares Liability (in shares)       714,000    
Issuance of shares to settle Additional Shares Liability $ 1,407       1,407  
Issuance of common stock upon exercise of stock options (in shares) 37,334     38,000    
Issuance of common stock upon exercise of stock options $ 71       71  
Issuance of common stock warrants 643       643  
Accretion on redeemable convertible preferred stock (976)       (976)  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)       1,224,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (1,743)       (1,743)  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)       100,000    
Shares issued in connection with the Employee Stock Purchase Plan 213       213  
Cancellation of Earn-Out Shares (in shares)       (197,000)    
Reduction in transaction costs 9,609       9,609  
Stock-based compensation 12,081       12,081  
Net loss (33,747)         (33,747)
Balances at ending of period (in shares) at Sep. 30, 2023       37,450,000    
Balances at ending of period at Sep. 30, 2023 $ 14,091     $ 4 625,692 (611,605)
Temporary equity, balances at beginning of period (in shares) at Jun. 30, 2023 0          
Temporary equity, balances at beginning of period at Jun. 30, 2023 $ 0          
Redeemable Convertible Preferred Stock            
Issuance of stock 9,024          
Accretion on redeemable convertible preferred stock $ 976          
Temporary equity, balances at ending of period (in shares) at Sep. 30, 2023 10,000          
Temporary equity, balances at ending of period at Sep. 30, 2023 $ 10,000          
Balances at beginning of period (in shares) at Jun. 30, 2023       36,438,000    
Balances at beginning of period at Jun. 30, 2023 21,141     $ 4 622,931 (601,794)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of shares to settle Additional Shares Liability (in shares)       714,000    
Issuance of shares to settle Additional Shares Liability 1,407       1,407  
Issuance of common stock warrants 643       643  
Accretion on redeemable convertible preferred stock (976)       (976)  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)       298,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (470)       (470)  
Stock-based compensation 2,157       2,157  
Net loss (9,811)         (9,811)
Balances at ending of period (in shares) at Sep. 30, 2023       37,450,000    
Balances at ending of period at Sep. 30, 2023 $ 14,091     $ 4 $ 625,692 $ (611,605)
[1] The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement